Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN IMMUNOGLOBULIN G\HYALURONIDASE for Immunodeficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 404 adverse event reports in the FDA FAERS database where HUMAN IMMUNOGLOBULIN G\HYALURONIDASE was used for Immunodeficiency.

Most Reported Side Effects for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

Side Effect Reports % Deaths Hosp.
Inappropriate schedule of product administration 610 20.8% 34 273
Covid-19 524 17.9% 23 246
Pneumonia 474 16.2% 36 308
Sinusitis 453 15.5% 6 192
Fatigue 448 15.3% 16 193
Headache 395 13.5% 9 174
Product dose omission issue 378 12.9% 15 192
Malaise 323 11.0% 16 160
Pyrexia 316 10.8% 23 197
Infusion site erythema 312 10.7% 19 103
Infusion site pain 285 9.7% 9 104
Infection 261 8.9% 13 136
Illness 255 8.7% 9 115
Insurance issue 253 8.6% 3 117
Pain 250 8.5% 6 120

Other Indications for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

Primary immunodeficiency syndrome (1,170) Immunodeficiency common variable (881) Secondary immunodeficiency (442) Product used for unknown indication (267) Hypogammaglobulinaemia (126) Chronic inflammatory demyelinating polyradiculoneuropathy (88) Immune system disorder (51) Plasma cell myeloma (49) Selective igg subclass deficiency (46) Hypergammaglobulinaemia (38)

Other Drugs Used for Immunodeficiency

HUMAN IMMUNOGLOBULIN G (2,648) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (224) CILGAVIMAB\TIXAGEVIMAB (76) DUPILUMAB (55) METRONIDAZOLE (35) MEROPENEM (28) VALACYCLOVIR (26) TOCILIZUMAB (24) ABATACEPT (23) FLUDARABINE (23)

Related Pages

HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Full Profile All Immunodeficiency Drugs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Demographics HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Timeline